FindTrial
Sign In

A Study to assess the effect of Teaching Programme on patients knowledge on chemotherapy medicines, their side effect and management of side effects at Cancer specialty hospital.

A Study to assess the effect of Structured Teaching Programme on knowledge of patients with Acute Myeloid Leukemia on Chemotherapy schedule, Side effects and its Management at a Tertiary cancer center

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012387
Enrollment
60
Registered
2018-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with Acute Myeloid Leukemia on Chemotherapy

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor
Not Any
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age above 18 years & diagnosed with AML 2.Patients planned 3+7 protocol chemotherapy 3.Patients receiving 3+7 protocol chemotherapy 4.Patients able to read, write understands Hindi/ English Marathi. 5.Registered with TMH.

Exclusion criteria

Exclusion criteria: 1.Relapsed AML 2.Paediatric patients 3.Patients those are not willing to participate. 4.Patient on maintenance 5.Palliative patients

Design outcomes

Primary

MeasureTime frame
Knowledge of patients on chemotherapy schedule, side effects and its management.Timepoint: 7 days after structured teaching programme—

Secondary

MeasureTime frame
Not anyTimepoint: Not any—

Countries

India

Contacts

Public ContactMs Rashmi Anand Methry

Tata memorial Center

prathepa_jagadish@rediffmail.com02224146560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026